All Stories

  1. Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels

    Article • The Aging Male, March 2019, Taylor & Francis

    Karim Sultan Haider

  2. Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study

    Article • Diabetes Care, March 2019, American Diabetes Association

    Karim Sultan Haider

  3. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality

    Article • The Aging Male, February 2019, Taylor & Francis

    Dr Ahmad Haider, Karim Sultan Haider

  4. Clinically occult prostate cancer cases may distort the effect of testosterone replacement therapy on risk of PCa

    Article • World Journal of Urology, January 2019, Springer Science + Business Media

    Karim Sultan Haider

  5. Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report

    Article • SAGE Open Medical Case Reports, January 2019, SAGE Publications

    Karim Sultan Haider

  6. Dynamic Patterns of Testosterone Levels in Individuals and Risk of Prostate Cancer among Hypogonadal Men: A Longitudinal Study

    Article • The Journal of Urology, February 2018, Wolters Kluwer Health

    Karim Sultan Haider

  7. Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study

    Article • The Journal of Urology, January 2018, Wolters Kluwer Health

    Karim Sultan Haider

  8. Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms

    Article • Investigative and Clinical Urology, January 2018, The Korean Urological Association (KAMJE)

    Karim Sultan Haider

  9. Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy

    Article • Endocrinology Diabetes and Metabolism Case Reports, September 2017, Bioscientifica

    Karim Sultan Haider

  10. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction

    Article • Hormone Molecular Biology and Clinical Investigation, June 2017, De Gruyter

    Karim Sultan Haider

  11. Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, February 2017, SAGE Publications

    Karim Sultan Haider

  12. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study

    Article • Vascular Health and Risk Management, June 2016, Dove Medical Press

    Professor Giuseppe M C Rosano, Karim Sultan Haider, Dr Ahmad Haider, Karim Sultan Haider

  13. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia

    Article • Hormone Molecular Biology and Clinical Investigation, January 2015, De Gruyter

    Karim Sultan Haider